A sneak peek into the life science technologies

The healthcare industry is all set to transform in the coming years. The new emerging, cutting-edge technologies in medical and life science are expected to redefine healthcare deliveries.

India is one of the fastest-growing life sciences markets in the world and the sector is poised to see multi-fold growth by 2030. Over the past decades, the Indian life sciences sector has witnessed exponential growth in terms of broadening scope, new research and development, and deepening of capabilities across the industry value chain.

The life sciences sector in India is composed of mainly three subsectors – pharmaceuticals, biotechnology/biopharma, and medical devices, each of which has played a prominent role in global/domestic markets in recent years. These subsectors are expected to witness accelerated growth in the coming years, led by various factors, such as policy interventions, infrastructure development, foreign direct investments (FDI), improved manufacturing capabilities, and access to a cost-effective talent pool.

Innovation in biotechnology and biomedicine happens when biology, chemistry, nanotechnology, physics, engineering, and data science come together. HORIBA has more than 30+ years of experience in the healthcare industry and has reached an international reputation, thanks to its high standards in terms of innovation. With its flexible production units and pioneering R&D centers, it is always a step ahead in developing products, always responding to market needs. HORIBA develops solutions that are adapted to its customers’ demands and anticipate their needs, thanks to technological creativity.

Forefront of biopharmaceutical advancements
Leveraging novel biomolecules and innovative delivery mechanisms to fight diseases, HORIBA is at the forefront of a biopharmaceutical revolution.

Precision in pharmaceutical development
For small molecule therapeutics, precision is paramount. Whether delivered through pills, capsules, or inhalation devices, the exact quantity, distribution, and size of components are crucial for efficacy. HORIBA’s cutting-edge Raman microscopy and particle-sizing technologies accelerate product development, troubleshoot issues, and identify contaminants with unmatched accuracy.

Biotechnology – From R&D to real-world applications
Biotechnology and biomedicine represent the convergence of biology, chemistry, and engineering. Advances in CRISPR-Cas9 gene editing, mRNA technology, and cell and gene therapies are pushing the boundaries of healthcare. HORIBA provides a unique portfolio of spectroscopy, imaging, and particle characterization tools that transform these discoveries into real-world applications, ultimately improving human health and well-being.

The science behind beauty
The creation of innovative cosmetics relies heavily on a deep understanding of biological matrices – skin, hair, and teeth. Our equipment caters to this need by analyzing everything from particle size in emulsions to hair chemistry. They also assess formulation composition, stability, and interaction with packaging, ensuring the safety and efficacy of these products.

Food safety – From farm to table
In today’s globalized food chain, ensuring the safety and integrity of food and beverages is paramount. HORIBA’s suite of analytical tools tackles this challenge head-on. They rapidly and precisely characterize particle size, chemical composition, and potential contaminants in crops, oils, spices, and nutraceuticals, safeguarding consumer health.

HORIBA will develop and deliver, innovative analytical and automation solutions, combining state-of-the-art, optical, electrochemical, Raman spectroscopy, and X-ray fluorescence technologies with core competencies in sampling, engineering, and data science. HORIBA will contribute to breakthroughs in drug development and manufacturing, leading to the adoption of new technologies, and contributing to healthier, more affordable, and more equitable health care for all.